C07C61/40 - CPC Classification Index

ClassID:

91987 ⎘

C07C61/40 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings; Unsaturated compounds containing halogen

Recent Application in this class:

20260048031

2026-02-19

POLYMORPHS OF CO-CRYSTALS OF ITANAPRACED AND NICOTINAMIDE

20230265038

2023-08-24

Crystal of tefluthrin, preparation method therefor and use thereof

20220242812

2022-08-04

SWELL1-LRRC8 COMPLEX MODULATORS

20210347759

2021-11-11

Method for manufacturing cyclopropane compound

20180265454

2018-09-20

Method for Producing 4-Oxoquinoline Compound

20180099919

2018-04-12

Process for the preparation of (1R,3R)- and (1S,3S)-2,2-dihalo-3-(substituted phenyl)cyclopropanecarboxylic acids

20160145186

2016-05-26

Non-ionic compound, resin, resist composition and method for producing resist pattern

20150253664

2015-09-10

Chemically-amplified positive resist composition and resist patterning process using the same

20140135399

2014-05-15

NOVEL POLYMORPHS AND SALTS

#10

20130267592

2013-10-10

Derivatives of 1-(2-halo-biphenyl-4-yl)-Alkanecarboxylic for the treatment of neurodegenerative diseases

#11

20120136167

2012-05-31

Processes for the preparation of optically active intermediates

#12

20120130097

2012-05-24

PROCESS FOR THE PREPARATION OF CYCLOPROPYL CARBOXYLIC ACID ESTERS AND DERIVATIVES

#13

20120095004

2012-04-19

Sphingosine kinase inhibitors

#14

20120071651

2012-03-22

Processes for preparing 1,2-substituted cyclopropyl derivatives

#15

20120065347

2012-03-15

FLUOROCOMPOUND HAVING HIGHLY FLUORINATED NORBORNANE STRUCTURE, FLUOROPOLYMER, AND THEIR PRODUCTION PROCESSES

#16

20110288175

2011-11-24

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#17

20110245346

2011-10-06

Polymorphs and salts

#18

20110190520

2011-08-04

Process for the preparation of cyclopropyl carboxylic acid esters and derivatives

#19

20110118354

2011-05-19

Cyclohexenyl modulators of chemokine receptor activity

#20

20110039934

2011-02-17

Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

#21

20100331575

2010-12-30

Processes for the preparation of optically active intermediates

#22

20100204199

2010-08-12

Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors

#23

20100099768

2010-04-22

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#24

20100035880

2010-02-11

Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists

#25

20090312426

2009-12-17

Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

#26

20090192330

2009-07-30

Fluorocompound having highly fluorinated norbornane structure, fluoropolymer, and their production processes

#27

20090036684

2009-02-05

Method for producing 4-oxoquinoline compound

#28

20080234249

2008-09-25

Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors

#29

20080167352

2008-07-10

Sphingosine kinase inhibitors

#30

20080071114

2008-03-20

Processes for the preparation of optically active intermediates

#31

20070060752

2007-03-15

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#32

20060287317

2006-12-21

Sphingosine kinase inhibitors

#33

20060258879

2006-11-16

Process for the preparation of cyclopropyl carboxylic acid esters and derivatives

#34

20060211741

2006-09-21

Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists